Questions Relating to 'Mitochondrial Replacement'
By Calum MacKellar,
BioNews
| 02. 10. 2014
Untitled Document
In his response (BioNews 738) to the article 'Should persons affected by mitochondrial disorders not be brought into existence?' (BioNews 736), Professor Sandy Raeburn is right to recognise the suffering experienced by some families affected by genetic disorders including those with disabling mitochondrial conditions. These are individuals and families in which very real suffering and deep distress are present. The compassionate work of Professor Raeburn, and many others like him, who have sought, or are seeking, to alleviate this suffering, through a number of medical treatments, can only be commended.
However, those who are concerned about the possibility of using maternal spindle transfer (MST) and pronuclear transfer (PT) to address mitochondrial disorders do not have any less compassion than those who believe that such procedures should be introduced. It is just that they remain to be convinced that all the biological and/or other risks have been sufficiently addressed.
Read more...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...